AD140 is an investigational selective androgen receptor modulator (SARM) developed as a future substitute for exogenous Testosterone replacement therapy (TRT). Some of the benefits under investigation are for the treatment of conditions such as muscle wasting and skeleton wasting (Osteoporosis), caused by breast cancer, RAD140 is currently under development by Radius Health, Inc.
In early 2020 a single case report of drug-induced liver injury following use of RAD 140 was published. RAD 140 is still is in the first stage of clinical trials with the results expected in late 2020. When released these trials will share the safety, toxicity, and potential adverse effects of RAD 140.
TLB150 Benzoate,is RAD140 O-Benzoate, esterified products enter cell membranes easily and decay in cells for a longer time. Which means TLB150 Benzoate is the update of RAD140, some also name it as RAD150.
Please check both differences as below sheet:
